Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/26 21:32 | 3/3/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | 2 | S.d | -401 | 19.17 | 0 | -21 | 98 | D | |||||||||||||||
3/3/26 21:31 | 2/2/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | 5 | S | -3,070 | 29.24 | 0 | -105 | 702 | D | |||||||||||||||
11/8/24 16:53 | 11/6/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | 1 | S | -246 | 36.76 | 0 | -7 | 27 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |